Pluribus Labs’s KKR & Co KKR Stock Holding History

Pluribus Labs’s Portfolio KKR Stock Details KKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,293	Closed	-$245K	–	152
2021 Q4	$245K	Buy	+3,293	New	+$243K	0.26%	173

Other funds holding KKR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACM

AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return

VVP

Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Pluribus Labs's KKR Position: Q1 2022 in Review

Pluribus Labs sold out of KKR & Co (KKR) in Q1 2022, closing a stake of 3,293 shares — an estimated $245K sold.

Pluribus Labs first reported a position in KKR in Q4 2021 and held it in 1 quarter. The position peaked at $245K in Q4 2021. 789 funds tracked by Wall St. Rank hold KKR as of Q1 2022.

Pluribus Labs reported no remaining KKR & Co position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 3,293 KKR & Co shares in Q1 2022, an estimated $245K.
Pluribus Labs first reported a position in KKR & Co in Q4 2021 and held it in 1 quarter.
Pluribus Labs's KKR & Co position peaked at $245K in Q4 2021.
789 funds tracked by Wall St. Rank held KKR & Co as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.